Results 41 to 50 of about 31,407 (156)

An overview of the clinical development of the 20-valent pneumococcal conjugate vaccine in adults

Human Vaccines & Immunotherapeutics
The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to expand protection against vaccine-preventable disease caused by Streptococcus pneumoniae beyond the 13-valent pneumococcal conjugate vaccine (PCV13).
Kathleen McElwee, Jelena Vojicic, Charulata Sabharwal, John Ginis, Yahong Peng, Gabriel Mircus, Wendy Watson, Annaliesa Anderson   +7 more
doaj   +1 more source

Pneumococcal vaccine development

Expert Review of Vaccines, 2004
A 7-valent pneumococcal conjugate vaccine has demonstrated an impact on pneumococcal bacteremia in the immunized pediatric population, extending to nonimmunized adults via herd immunity. A considerable reduction of all-cause pediatric pneumonia has also been found.
openaire   +2 more sources

Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study

The Lancet Public Health
Summary: Background: Paediatric pneumococcal conjugate vaccine (PCV) programmes in England using seven-valent PCV (PCV7) in 2006 and 13-valent PCV (PCV13) in 2010 have reduced vaccine-type invasive pneumococcal disease, but the overall effect has been ...
Yoon Hong Choi, PhD, Marta Bertran, MSc, David J Litt, PhD, Shamez N Ladhani, ProfPhD, Elizabeth Miller, ProfFMedSci   +4 more
doaj   +1 more source

Effectiveness of the polysaccharide pneumococcal vaccine among HIV-infected persons in Brazil: a case control study

BMC Infectious Diseases, 2007
Background Polysaccharide pneumococcal vaccine is recommended for use in HIV-infected adults in Brazil but there is uncertainty about its effectiveness in this patient population. The main objective of this study was to assess the effectiveness of the 23-
Veras Maria, Enanoria Wayne TA, Castilho Euclides A, Reingold Arthur L   +3 more
doaj   +1 more source

Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)

Lung India
Introduction Pneumococcal diseases pose a significant public health concern in India, with substantial morbidity and mortality, with the elderly and those with coexisting medical conditions being most at risk.
Parvaiz A. Koul, Agam C. Vora, Surinder K. Jindal, Venkatasubramanian Ramasubramanian, Varsha Narayanan, Surya Kant Tripathi, Digambar Bahera, Harway Bhaskar Chandrashekhar, Ravindra Mehta, Narendra Raval, Prabhakar Dorairaj, Prashant Chhajed, Akash Balki, Rohan Ketan Aurangabadwalla, Abhijeet Khandelwal, Mahendra Kawedia, Satya Prakash Rai, Ashok Grover, Manish Sachdev, Surajit Chatterjee, Velamuru V. Ramanaprasad, Aratrika Das, Mahavir Madhavdas Modi   +22 more
doaj   +1 more source

PROGNOSTICATION OF VACCINATION EFFICACY

Педиатрическая фармакология, 2010
The article focuses on the study of protective immunity in vaccination with pneumococcal conjugated 7-valent vaccine (PCV7) against related vaccine serotypes.
N.F. Snegova, S.M. Kharit, V.K. Tatochenko, M.P. Kostinov   +3 more
doaj   +2 more sources

Global Coverage of Pneumococcal Conjugate Vaccine (PCV) and Serotype Distribution after Receiving Vaccine among Targeted PCV Vaccine Countries: A Systematic Review

مجله اپیدمیولوژی ایران, 2020
Background and Objectives: After the introduction of the pneumococcal vaccine, an increase has been observed in the disease due to nonspecific stereotypes of the vaccine.
S Rahmani, m Karami, , M Adabi, A Doosti Irani   +4 more
doaj  

Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era

Frontiers in Medicine, 2019
Background: Pneumococcal pneumonia is a disease of the extremes of age. However, as other traditional risk factors for pneumococcal pneumonia also increase with older age, it is unclear if older age itself should be an indication for pneumococcal ...
Werner C. Albrich, Frank Rassouli, Frederike Waldeck, Christoph Berger, Florent Baty   +4 more
doaj   +1 more source

Pneumococcal vaccine [PDF]

Paediatrics & Child Health, 2002
openaire   +3 more sources

PNEUMOCOCCAL INFECTION IN RUSSIA: EPIDEMIOLOGICAL SITUATION

Педиатрическая фармакология, 2010
The article features an analysis of available literature on the incidence, etiological characteristics, clinical forms of pneumococcal infections in the Russian Federation with a break-down by age group highlighting risk factors. It provides clinical and
I.S. Koroleva, S.M. Kharit, A.A. Ruleva, A.L. Perova, S.V. Sidorenko   +4 more
doaj   +2 more sources